GlaxoSmithKline, the pharmaceutical manufacturer of Excedrin, has temporarily suspended the production of two of its most popular medications to relieve headaches after discovering "inconsistencies in the way we transfer and weigh the ingredients," it said in a statement.
The products affected by the suspension are Excedrin Extra Strength and Excedrin Migraine, both in tablets and in gel capsules, which are a compound of aspirin, caffeine and aceminatophen.
The pharmacist says that she does not believe both drugs represent a risk to the safety of consumers but made the decision as a precaution and hopes to resume production "shortly".
However, other forms and presentations of medicine will still be available in pharmacies.
However, the company advised patients to consult pharmacists because the dose may be different.
On the other hand, the medicine correspondent of the NBC News Today Show, John Torres, recommended asking in his pharmacy for other products that are sold without a prescription and are composed of the same chemicals.
In addition, he warned that those people who abuse the same medicine to fight the headache may stop feeling no or very little relief.
